Biotinylated SARS-CoV-2 Spike RBD (Wild type)

<strong>Biotinylated SARS-CoV-2 Spike RBD (Wild type)</strong>_x000D_ <strong>Catalog number:</strong> B2010506_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 25 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 27 kDa_x000D_ <strong>Supplied as:</strong> Liquid Solution_x000D_ <strong>Applications:</strong> molecular component of many serological and antigenic assays for SARS-CoV-2_x000D_ <strong>Storage:</strong> -20℃_x000D_ <strong>Keywords:</strong> Spike RBD, S1 RBD, Wild Type RBD, Biotin RBD_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <a href="https://moleculardepot.com/wp-content/uploads/2022/03/MKT-010-SARS-CoV-2-Brochure-Rev-A.pdf"><strong>Download SARS-CoV-2 Brochure</strong></a>_x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Kadam SB, Sukhramani GS, Bishnoi P, Pable AA, Barvkar VT. SARS-CoV-2, the_x000D_ pandemic coronavirus: Molecular and structural insights. J Basic Microbiol. 2021_x000D_ Mar;61(3):180-202._x000D_ _x000D_ 2: Liu Z, Xu W, Xia S, Gu C, Wang X, Wang Q, Zhou J, Wu Y, Cai X, Qu D, Ying T,_x000D_ Xie Y, Lu L, Yuan Z, Jiang S. RBD-Fc-based COVID-19 vaccine candidate induces_x000D_ highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target_x000D_ Ther. 2020 Nov 27;5(1):282._x000D_ _x000D_ 3: Ma X, Zou F, Yu F, Li R, Yuan Y, Zhang Y, Zhang X, Deng J, Chen T, Song Z,_x000D_ Qiao Y, Zhan Y, Liu J, Zhang J, Zhang X, Peng Z, Li Y, Lin Y, Liang L, Wang G,_x000D_ Chen Y, Chen Q, Pan T, He X, Zhang H. Nanoparticle Vaccines Based on the_x000D_ Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust_x000D_ Protective Immune Responses. Immunity. 2020 Dec 15;53(6):1315-1330.e9._x000D_ _x000D_ 4: Huang WC, Zhou S, He X, Chiem K, Mabrouk MT, Nissly RH, Bird IM, Strauss M,_x000D_ Sambhara S, Ortega J, Wohlfert EA, Martinez-Sobrido L, Kuchipudi SV, Davidson_x000D_ BA, Lovell JF. SARS-CoV-2 RBD Neutralizing Antibody Induction is Enhanced by_x000D_ Particulate Vaccination. Adv Mater. 2020 Dec;32(50):e2005637._x000D_ _x000D_ 5: Figueiredo-Campos P, Blankenhaus B, Mota C, Gomes A, Serrano M, Ariotti S,_x000D_ Costa C, Nunes-Cabaço H, Mendes AM, Gaspar P, Pereira-Santos MC, Rodrigues F,_x000D_ Condeço J, Escoval MA, Santos M, Ramirez M, Melo-Cristino J, Simas JP,_x000D_ Vasconcelos E, Afonso Â, Veldhoen M. Seroprevalence of anti-SARS-CoV-2_x000D_ antibodies in COVID-19 patients and healthy volunteers up to 6 months post_x000D_ disease onset. Eur J Immunol. 2020 Dec;50(12):2025-2040._x000D_ _x000D_ 6: Luan J, Jin X, Lu Y, Zhang L. SARS-CoV-2 spike protein favors ACE2 from_x000D_ Bovidae and Cricetidae. J Med Virol. 2020 Sep;92(9):1649-1656._x000D_ _x000D_ 7: Zhou H, Chen X, Hu T, Li J, Song H, Liu Y, Wang P, Liu D, Yang J, Holmes EC,_x000D_ Hughes AC, Bi Y, Shi W. A Novel Bat Coronavirus Closely Related to SARS-CoV-2_x000D_ Contains Natural Insertions at the S1/S2 Cleavage Site of the Spike Protein._x000D_ Curr Biol. 2020 Jun 8;30(11):2196-2203.e3._x000D_ _x000D_ 8: Li K, Huang B, Wu M, Zhong A, Li L, Cai Y, Wang Z, Wu L, Zhu M, Li J, Wang Z,_x000D_ Wu W, Li W, Bosco B, Gan Z, Qiao Q, Wu J, Wang Q, Wang S, Xia X. Dynamic changes_x000D_ in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from_x000D_ COVID-19. Nat Commun. 2020 Nov 27;11(1):6044._x000D_ _x000D_ 9: Singh SP, Pritam M, Pandey B, Yadav TP. Microstructure, pathophysiology, and_x000D_ potential therapeutics of COVID-19: A comprehensive review. J Med Virol. 2021_x000D_ Jan;93(1):275-299._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33031947/">10: Diao B, Wen K, Zhang J, Chen J, Han C, Chen Y, Wang S, Deng G, Zhou H, Wu Y._x000D_ Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-_x000D_ CoV-2 infection. Clin Microbiol Infect. 2021 Feb;27(2):289.e1-289.e4. </a>_x000D_ _x000D_ <strong>Products Related to Biotinylated SARS-CoV-2 Spike RBD (Wild type)</strong><a href="https://moleculardepot.com/product-category/SARS-CoV-2/">: SARS-CoV-2</a>